Detalles de la búsqueda
1.
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.
Acta Derm Venereol;
102: adv00698, 2022 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35146532
Resultados
1 -
1
de 1
1
Próxima >
>>